MASON, Ohio--(BUSINESS WIRE)-- AtriCure, Inc. (Nasdaq: ATRC), a leading innovator in surgical treatments and therapies for atrial fibrillation (Afib), left atrial appendage (LAA) management and ...
AtriCure, Inc. ATRC, a leading innovator in surgical treatments for atrial fibrillation (Afib), has announced regulatory approval for its EnCompass Clamp in CE-marked countries within the European ...
MASON, Ohio--(BUSINESS WIRE)--AtriCure, Inc. (Nasdaq: ATRC), a leading innovator in surgical treatments and therapies for atrial fibrillation (Afib), left atrial appendage (LAA) management, and ...
MASON, Ohio - AtriCure, Inc. (NASDAQ: ATRC), a company specializing in medical devices for atrial fibrillation (Afib) and related conditions, has recently obtained regulatory approval to market its ...
The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results